IP Library › Granted Patent US 12,357,196
Granted Patent B2
US 12,357,196 · App. 18/230,417 · Granted Jul 15, 2025

Neurosleeve for closed loop EMG-FES based control of pathological tremors

Inventors: Gaurav Sharma (Lewis Center, OH); Patrick Ganzer (Columbus, OH)
Assignee: BATTELLE MEMORIAL INSTITUTE
A61B5/1101A61B5/296A61B5/6824A61B5/6828A61B5/6829A61B5/7225A61B5/7264A61N1/0452A61N1/0456A61N1/0484A61N1/36031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,357,196
App. No.
18/230,417
Granted
Jul 15, 2025
Kind
B2
Abstract

A tremor suppression device includes a garment wearable on an anatomical region and including electrodes contacting the anatomical region when the garment is worn on the anatomical region, and an electronic controller configured to: detect electromyography (EMG) signals as a function of anatomical location and time using the electrodes; identify tremors as a function of anatomical location and time based on the EMG signals; and apply neuromuscular electrical stimulation (NMES) at one or more anatomical locations as a function of time using the electrodes to suppress the identified tremors.

Claims (35)

1. A tremor suppression method comprising:

using a garment worn on an anatomical region of a patient and including an array of electrodes disposed on an inside of the garment and contacting the anatomical region, measuring baseline tremors in the anatomical region; and

performing closed-loop feedback controlled tremor suppression including:

applying a tremor suppression therapy to the patient;

measuring modified tremors in the anatomical region during or after the applying of the tremor suppression therapy to the patient; and

tuning the tremor suppression therapy applied to the patient based on the measured modified tremors while repeating the applying and the measuring of the modified tremors until the measuring of the modified tremors indicates that tremor suppression is achieved.

2. The tremor suppression method of claim 1 , wherein the modified tremors in the anatomical region are measured as a function of time.

3. The tremor suppression method of claim 1 , wherein the applying of the tremor suppression therapy to the patient comprises:

applying an electrical stimulation to the patient by Vagus Nerve Stimulation (VNS) using a nerve stimulation interface.

4. The tremor suppression method of claim 1 , wherein wherein the applying of the tremor suppression therapy to the patient comprises:

applying an electrical stimulation to the patient by Direct Brain Stimulation (DBS) using a nerve stimulation interface.

5. The tremor suppression method of claim 1 , wherein the using of the garment to measure modified tremors in the anatomical region is performed during the applying of the tremor suppression therapy to the patient.

6. The tremor suppression method of claim 1 , wherein the garment is a sleeve and the anatomical region is an arm, a leg, a wrist, an ankle, an arm and a wrist, or a leg and an ankle.

7. The tremor suppression method of claim 1 , wherein the anatomical region is at least one of an arm, a wrist and/or a hand, or a leg, an ankle, and/or a foot.

8. A tremor suppression method comprising:

using a garment worn on an anatomical region of a patient and including an array of electrodes disposed on an inside of the garment and contacting the anatomical region, measuring baseline tremors in the anatomical region; and

performing closed-loop feedback controlled tremor suppression including:

applying an electrical stimulation to the patient by Vagus Nerve Stimulation (VNS) using a nerve stimulation interface;

measuring modified tremors in the anatomical region as a function of time during or after the applying of the electrical stimulation by VNS; and

tuning the electrical stimulation to the patient by VNS based on the modified tremors measured as a function of time while repeating the applying and the measuring of the modified tremors until the measuring of the modified tremors indicates that tremor suppression is achieved.

9. The tremor suppression method of claim 8 , wherein the using of the garment to measure modified tremors in the anatomical region is performed during the electrical stimulation by VNS.

10. The tremor suppression method of claim 8 , wherein the garment is a sleeve and the anatomical region is an arm, a leg, a wrist, an ankle, an arm and a wrist, or a leg and an ankle.

11. The tremor suppression method of claim 8 , wherein the anatomical region is at least one of an arm, a wrist and/or a hand, or a leg, an ankle, and/or a foot.

12. A tremor suppression apparatus comprising:

a tremor suppression therapy device;

a garment configured to be worn on an anatomical region of the patient and including an array of electrodes disposed on an inside of the garment and contacting the anatomical region when the garment is worn on the anatomical region; and

an electronic processor configured to measure baseline tremors in the anatomical region using the electrodes disposed on the inside of the garment, and to perform closed-loop feedback controlled tremor suppression including:

applying tremor suppression therapy to the patient using the tremor suppression therapy device;

during or after the applying of the tremor suppression therapy to the patient, measuring modified tremors in the anatomical region using the electrodes disposed on the inside of the garment; and

tuning the tremor suppression therapy applied to the patient based on the measured modified tremors while repeating the applying and the measuring of the modified tremors until the measuring of the modified tremors indicates that tremor suppression is achieved.

13. The tremor suppression apparatus of claim 12 , wherein the modified tremors in the anatomical region are measured as a function of time.

14. The tremor suppression apparatus of claim 12 , wherein the tremor suppression therapy device comprises a nerve stimulation interface configured to perform Vagus Nerve Stimulation (VNS), and the applying of the tremor suppression therapy to the patient comprises applying an electrical stimulation to the patient by VNS using the nerve stimulation interface.

15. The tremor suppression apparatus of claim 12 , wherein the tremor suppression therapy device comprises a nerve stimulation interface configured to perform Direct Brain Stimulation (DBS), and the applying of the tremor suppression therapy to the patient comprises applying an electrical stimulation to the patient by DBS using the nerve stimulation interface.

16. The tremor suppression apparatus of claim 12 , wherein the modified tremors in the anatomical region are measured during the applying of the tremor suppression therapy to the patient using the tremor suppression therapy device.

17. The tremor suppression apparatus of claim 12 , wherein the garment is a sleeve and the anatomical region is an arm, a leg, a wrist, an ankle, an arm and a wrist, or a leg and an ankle.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2023
From: SHARMA, GAURAV; GANZER, PATRICK
To: BATTELLE MEMORIAL INSTITUTE
Reel/Frame 064497/0524 →
Continuity (5)
Continuation 17008199 · Aug 31, 2020
Continuation In Part 17002135 · Aug 25, 2020
Continuation PCTUS2020039802 · Jun 26, 2020
Provisional Application 62868158 · Jun 28, 2019
Related Publication 20230371846A1 · Nov 23, 2023
References Cited (21)
US 6463328B1 · John · 2002 [cited by applicant]
US 7151961B1 · Whitehurst et al. · 2006 [cited by applicant]
US 8121694B2 · Molnar et al. · 2012 [cited by applicant]
US 9452287B2 · Rosenbluth et al. · 2016 [cited by applicant]
US 11160971B2 · Sharma · 2021 [cited by applicant]
US 11766191B2 · Sharma · 2023 [cited by examiner]
US 20070123951A1 · Boston · 2007 [cited by applicant]
US 20080288020A1 · Einav et al. · 2008 [cited by applicant]
US 20100174342A1 · Boston et al. · 2010 [cited by applicant]
US 20150290421A1 · Bouton · 2015 [cited by applicant]
US 20150290451A1 · Bouton et al. · 2015 [cited by applicant]
US 20150306373A1 · Bouton et al. · 2015 [cited by applicant]
US 20180081439A1 · Daniels · 2018 [cited by applicant]
US 20190142339A1 · Thommandram et al. · 2019 [cited by applicant]
US 20200405188A1 · Sharma et al. · 2020 [cited by applicant]
EP 2801389A1 · 2014 [cited by applicant]
WO WO2014089266A2 · 2014 [cited by applicant]
WO WO2014113813A1 · 2014 [cited by applicant]
WO WO2018098046A2 · 2018 [cited by applicant]
WO WO2019126080A1 · 2019 [cited by applicant]
International Search Report dated Oct. 16, 2020 from PCT/US2020/039802. [cited by applicant]
Cited By (2)
US 12,741,137 US 12,746,390